{
    "id": 1623,
    "fullName": "KIT S476I",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "KIT S476I lies within the Ig-like C2-type domain 5 (exon 9) of the Kit protein (UniProt.org). S476I confers a gain of function on Kit, as indicated by constitutive phosphorylation of Kit in cell culture (PMID: 19865100, PMID: 30094412).",
            "references": [
                {
                    "id": 646,
                    "pubMedId": 19865100,
                    "title": "Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19865100"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12217,
                    "pubMedId": 30094412,
                    "title": "Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in KIT-Mutant Melanoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30094412"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "S476I",
    "createDate": "09/07/2014",
    "updateDate": "05/15/2019",
    "referenceTranscriptCoordinates": {
        "id": 136624,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54725937G>T",
        "cDna": "c.1427G>T",
        "protein": "p.S476I",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11811,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Tasigna (nilotinib) decreased proliferation of patient-derived neoplastic mast cells harboring KIT S476I in culture (PMID: 25209843).",
            "molecularProfile": {
                "id": 1637,
                "profileName": "KIT S476I"
            },
            "therapy": {
                "id": 829,
                "therapyName": "Nilotinib",
                "synonyms": null
            },
            "indication": {
                "id": 9254,
                "name": "mast-cell leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9857,
                    "pubMedId": 25209843,
                    "title": "Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25209843"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11810,
            "approvalStatus": "Preclinical - Patient cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, treatment with Rydapt (midostaurin) decreased proliferation of patient-derived neoplastic mast cells harboring KIT S476I in culture (PMID: 25209843).",
            "molecularProfile": {
                "id": 1637,
                "profileName": "KIT S476I"
            },
            "therapy": {
                "id": 810,
                "therapyName": "Midostaurin",
                "synonyms": null
            },
            "indication": {
                "id": 9254,
                "name": "mast-cell leukemia",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 9857,
                    "pubMedId": 25209843,
                    "title": "Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25209843"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7766,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, a GIST patient harboring KIT S476I and MET R988C demonstrated sensitivity to the combination treatment, Nexavar (sorafenib) and Avastin (bevacizumab), resulting in stable disease for 6 months (PMID: 25363205).",
            "molecularProfile": {
                "id": 26035,
                "profileName": "KIT S476I MET R988C"
            },
            "therapy": {
                "id": 4517,
                "therapyName": "Bevacizumab + Sorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 9253,
                "name": "gastrointestinal stromal tumor",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6478,
                    "pubMedId": 25363205,
                    "title": "Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25363205"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1637,
            "profileName": "KIT S476I",
            "profileTreatmentApproaches": [
                {
                    "id": 1900,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT S476I"
                }
            ]
        },
        {
            "id": 26035,
            "profileName": "KIT S476I MET R988C",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 136625,
            "transcript": "NM_001093772",
            "gDna": "chr4:g.54725937G>T",
            "cDna": "c.1427G>T",
            "protein": "p.S476I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136624,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54725937G>T",
            "cDna": "c.1427G>T",
            "protein": "p.S476I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136626,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54725937G>T",
            "cDna": "c.1427G>T",
            "protein": "p.S476I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136627,
            "transcript": "XM_017008180",
            "gDna": "chr4:g.54725937G>T",
            "cDna": "c.1427G>T",
            "protein": "p.S476I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}